Search results
Results from the WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB. The medical standard for active TB is a short course treatment involving a combination of isoniazid , rifampicin (also known as Rifampin), pyrazinamide , and ethambutol for the first two months.
The Insular Board of Health was given the power to draft legislation for sanitary and medical practices in the Philippines. They were tasked with studying diseases and prevention methods, as well as overseeing public health. [17] The Board of Health made strategies to counter many diseases like leprosy.
The Philippine Medical Care Program began in 1971 following the Philippine Medical Care Act of 1969. [6] It mandated creation of the Philippine Medical Care Commission (PMCC). In 1990, bills were passed that led to significant improvement of public health care insurance.
The Department of Health (DOH; Filipino: Kagawaran ng Kalusugan) is the executive department of the government of the Philippines responsible for ensuring access to basic public health services by all Filipinos through the provision of quality health care, the regulation of all health services and products.
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
As of September 2020, the Philippines has a population of nearly 110 million and a population density of 368 per square kilometer. 32% of the population of the Philippines is under 15 years old, and only 22.2% is over 60. In the Philippines, 16.6% of the population lived below the national poverty line in 2018. [8] [9]
The Global Fund’s investments have reduced deaths from HIV, tuberculosis, and malaria by 61% since 2002, saving 65 million lives. [27] Recent efforts include lowering the cost of key treatments for drug-resistant TB by 55% and first-line HIV medications by 25%, while introducing a more effective insecticide-treated mosquito net. [28]
The cost of treating a single case of multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB (XDR-TB) can be thousands of times more expensive than treating drug-sensitive TB. [7] TB is also the number one killer of people with AIDS, but it is generally agreed that current TB treatments do not work well with the antiretroviral drugs ...